Isotope Production Capabilities at Texas A{\&}M University Cyclotron Institute

Radioisotopes for targeted alpha therapy are of increased interest of late at the Cyclotron Institute at Texas A{\&}M University. Astatine-211 shows great promise for cancer treatment, and its chemistry is not very well understood. Current efforts focus on the development of bismuth targets for astatine-211 production via the Bi-209($\alpha $,2n)At-211 nuclear reaction, followed by a chemical separation of the astatine-211 from the bulk bismuth. Other alpha-emitting radionuclides may also be produced using heavy ion beams. The state of the program will be discussed.